CHMP Recommended Granting Marketing Authorization For Elahere For The Treatment Of Adults With Ovarian Cancer, Fallopian Tube Cancer, Or Primary Peritoneal Cancer
CHMP Recommended Granting Marketing Authorization For Elahere For The Treatment Of Adults With Ovarian Cancer, Fallopian Tube Cancer, Or Primary Peritoneal Cancer
CHMP建議授予Elahere治療卵巢癌、輸卵管癌或原發性腹膜癌的成年人的市場授權。
CHMP Recommended Granting Marketing Authorization For Elahere For The Treatment Of Adults With Ovarian Cancer, Fallopian Tube Cancer, Or Primary Peritoneal Cancer
CHMP建議授予Elahere治療卵巢癌、輸卵管癌或原發性腹膜癌的成年人的市場授權。